Get 20% Free Customization In This Report
Buy this report from - $3111

Antiemetics Market by Type (5-HT3 receptor antagonists, Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, and Steroids), Application (Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning) - Global Opportunity Analysis and Industry Forecast, 2017-2023

LI 17435
Pages: NA
Apr 2018 | 1672 Views
face gplus_n
Author's : NA
Tables: NA
Charts: NA
twit_n pr_n

Antiemetics are therapeutic agents that are effective against nausea and vomiting. Nausea and vomiting are the symptoms of several medical conditions such as motion sickness, dizziness, pregnancy, emotional stress and food poisoning. These drugs are often used to treat the side effects of other medications including opioid analgesics, Chemotherapy and general anesthetics. Global antiemetics market is expected to grow with healthy CAGR during the forecast period due to increase in number of patients suffering from cancer and increased number of surgeries. In-depth discussion of global antiemetics market includes past and current trends with future forecast up to 2020. Profound assessment of threats and opportunities for new and existing companies running the business in this market would be beneficial to strategist in their respective decision making process. The report is informative towards geographical segmentation and identifies profitable areas.

Over the few years, antiemetics have witnessed sudden increase in sale due to increasing number of cancer patients. Nausea and vomiting are the common symptoms of chemotherapy and high risk chemotherapeutic agents include Carmustine and Cisplatin. Additional market drivers include extensive research activities to innovate universal antiemetic drug therapy, use of novel drug delivery to improve patient compliance and identification of new drug targets. However, the antiemetic drugs, which are in clinical phase requires improvement in clinical trial design for their commercialization. Moreover, lack of suitable animal model that will mimic the human responses to antiemetic therapy also restraints the market growth. Novel drug therapies and new drug targets are the opportunities for manufacturers that would help them to increase their market share. 

Global Antiemetics Market by Type

The antiemetics market is segmented by type of drugs into different categories such as 5-HT3 receptor antagonists, Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids and Others. 5-HT3 receptor antagonists, Dopamine antagonists and Cannabinoids are popular categories of antiemetics. Dronabinol is the largest selling drug from Cannabinoids, whereas Domperidone dominates the dopamine antagonists. Ondansetron, Dolasetron and Palonosetron are the top selling drugs from 5-HT3 receptor antagonists. 

Global Antiemetics Market by Application

Antiemetics are used to treat the emesis arising from several medical conditions and include Chemotherapy, Motion sickness, Gastroenteritis, general anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress and Others. Chemotherapy leads the application segment as number of patients suffering from cancer is increasing day by day.

Global Antiemetics Market by Geography

Geographically, global antiemetics market is segmented into North America, Europe, Asia-pacific and LAMEA. North America and Europe leads the global antiemetics market due to high incidence of cancer. Asia-Pacific is the fastest growing market due to increasing number of cancer population, high incidences of gastroenteritis and other diseases that lead to nausea and vomiting.

Competitive Landscape

The leading companies in global antiemetics market include GlaxoSmithCline, Merck, Sanofi-Aventis, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Astellas Pharma, Johnson & Johnson, Baxter International and others. Antiemetics market has witnessed a strong competition due to large number of companies are trying to focus their R&D efforts to manufacture universal antiemetic therapy, which would offer improved patient compliance. Competitors are also focusing on novel drug deliveries that would show better outcomes as compared to conventional therapies.

High Level Analysis

The study identifies the potential market drivers, challenges and trends. Competitive landscape section provides explicit information of the top players ruling the global antiemetics market, their operating strategies, new launches, pipeline therapies and clinical trials. Porter’s Five Forces analysis has been used to determine the attractiveness of global antiemetics market. Market landscape for antiemetics is varied and contains numerous big and small players. Moreover, demand for antiemetic drugs is high due to increasing number of cancer population and diseases that lead to nausea and vomiting. Hence, supplier’s power is moderate for global antiemetics market. Antiemetics are the secondary indication for many of the medical conditions and it fascinates new companies to enter the market. Industrial rivalry is intense due to exhaustive R&D activities and clinical trials to innovate the universal antiemetic therapy.


  • This report offers the following benefits in particular:
  • Comprehensive coverage of global antiemetics market along with disease overview, market trends, drivers and restraints would assist strategist in their respective business decisions
  • Thorough attention is given to leading company portfolios, pipeline research, new launches and competitive landscape of top players
  • Explicit information on current clinical trials and R&D activities would be beneficial to understand the future market trends  
  • Insightful analysis of different segments helps to recognize and capitalize future opportunities within global antiemetics market


The global antiemetic drugs market is segmented into three major categories such as type, application and geography. 


  • 5-HT3 receptor antagonists
  • Dopamine antagonists
  • NK1 receptor antagonist
  • Antihistamines (H1 histamine receptor antagonists)
  • Cannabinoids
  • Benzodiazepines
  • Anticholinergics
  • Steroids
  • Others


  • Chemotherapy
  • Motion sickness
  • Gastroenteritis
  • General anesthetics
  • Opioid analgesics
  • Dizziness
  • Pregnancy
  • Food poisoning
  • Emotional stress
  • Others


  • North America
  • Europe
  • Asia-Pacific
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.


Get More Information About This Report

For any queries about purchasing this report, Please fill the form below:

Please input the above text in the input box or click refresh









* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at

Send Enquiry

Why Allied Market Research


Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Featured Readings


Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts